Home › NDC Lookup › RxCUI directory › RxCUI 313222

Terbinafine 250 MG Oral Tablet — RxCUI 313222

RxNorm drug concept · Semantic clinical drug
RxCUI 313222 Semantic clinical drug · SCD ● Current RxNorm concept 41 FDA products 113 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI313222
Official nameTerbinafine 250 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asterbinafine (as terbinafine HCl) 250 MG Oral Tablet; terbinafine HCl 250 MG Oral Tablet
FDA products mapped41
Package NDCs mapped113
Reported Medicaid activity (SDUD)407,419 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Terbinafine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's one of the most common questions I get with this medication. The tablets clear the fungus, but your nail has to physically grow out before it looks healthy — and that can ta...
  • How long will it take for my nail to look normal after I finish the tablets?
  • Yes — and the big one is your liver. If you notice yellowing of your skin or eyes, dark urine, pale-colored stools, or you feel unusually tired and nauseous, stop the tablets and c...
  • Are there any side effects I should actually call my doctor about?
📖 Read our full Terbinafine guide →

🕸️ Concept Web — How Terbinafine 250 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Terbinafine 250 MG Oral Tablet RxCUI 313222

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Terbinafine 37801
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Terbinafine Oral Tablet 374036
    • Terbinafine Oral Product 1161495
    • Terbinafine Pill 1161496
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Terbinafine 250 MG 329055

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Terbinafine 250 MG SCDC · 329055
  • Terbinafine Oral Tablet SCDF · 374036
  • Terbinafine Oral Product SCDG · 1161495
  • Terbinafine Pill SCDG · 1161496

📦 FDA Products & Package NDCs

41 products · 113 package NDCs
113 package NDCs map to RxCUI 313222 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71335-9677-08 14 TABLET in 1 BOTTLE, PLASTIC (71335-9677-8) terbinafine hydrochloride Bryant Ranch Prepack 2023-05-10
71335-9677-09 28 TABLET in 1 BOTTLE, PLASTIC (71335-9677-9) terbinafine hydrochloride Bryant Ranch Prepack 2023-05-10
72162-1595-01 100 TABLET in 1 BOTTLE (72162-1595-1) Terbinafine Hydrochloride Bryant Ranch Prepack 2024-02-07
72162-2539-01 100 TABLET in 1 BOTTLE (72162-2539-1) Terbinafine Bryant Ranch Prepack 2025-09-18
72162-2539-03 30 TABLET in 1 BOTTLE (72162-2539-3) Terbinafine Bryant Ranch Prepack 2025-09-18
72189-0243-30 30 TABLET in 1 BOTTLE (72189-243-30) TERBINAFINE direct rx 2021-07-23
72789-0394-42 42 TABLET in 1 BOTTLE, PLASTIC (72789-394-42) Terbinafine PD-Rx Pharmaceuticals, Inc. 2024-08-05
72789-0394-90 90 TABLET in 1 BOTTLE, PLASTIC (72789-394-90) Terbinafine PD-Rx Pharmaceuticals, Inc. 2024-04-16
76282-0209-01 100 TABLET in 1 BOTTLE (76282-209-01) Terbinafine Exelan Pharmaceuticals Inc. 2012-04-25
76282-0209-05 500 TABLET in 1 BOTTLE (76282-209-05) Terbinafine Exelan Pharmaceuticals Inc. 2012-04-25
76282-0209-30 30 TABLET in 1 BOTTLE (76282-209-30) Terbinafine Exelan Pharmaceuticals Inc. 2012-04-25
82804-0220-30 30 TABLET in 1 BOTTLE, PLASTIC (82804-220-30) terbinafine hydrochloride Proficient Rx LP 2025-04-24
82804-0220-42 42 TABLET in 1 BOTTLE, PLASTIC (82804-220-42) terbinafine hydrochloride Proficient Rx LP 2025-09-04
Observed labelers: Bryant Ranch Prepack (31) · Proficient Rx LP (23) · A-S Medication Solutions (8) · REMEDYREPACK INC. (8) · Cipla USA Inc. (5) · Dr.Reddys Laboratories Limited (5) · +15 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.